Khosla, VCs plow US$100m into blood test startup using AI

Khosla, VCs plow US$100m into blood test startup using AI
(Image: Bloomberg)
Bloomberg
(Bloomberg) -- Blood-testing company Karius Inc. raised US$100 million (NZ$166.8m) in a new funding round from investors, and will use the cash to get its technology for detecting hard-to-identify infections into more hospitals. The funding round was led by existing investor Khosla Ventures alongside 5AM Ventures and Gilde Healthcare. The company declined to give its valuation. Redwood City, California-based Karius’ blood tests look for pathogens by comparing fragments of microbial DNA with a database of 20,000 genomic reference...

More Technology

First NZ-made aluminium cans set to roll off Recorp's line
Technology

First NZ-made aluminium cans set to roll off Recorp's line

Operations were delayed by months because the machinery was too big for the building.

Greg Hurrell 02 Jul 2024
Scott Tech lands two new deals worth $19m
Markets

Scott Tech lands two new deals worth $19m

Scott has a new deal with existing customer Danone and has nabbed a new UK customer.

Ben Moore 02 Jul 2024
Tech industry wants to lock up nuclear power for AI
Technology

Tech industry wants to lock up nuclear power for AI

The largest tech companies are looking to buy nuclear power directly from plants.

Being AI sues investment bank for defamation
Markets

Being AI sues investment bank for defamation

Chair Sean Joyce says the bank has doubled down on highly defamatory allegations.